DAVID C BUPP Insider Trading $NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID C BUPP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID C BUPP. DAVID C BUPP is CEO and President in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
DAVID C BUPP in NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID C BUPP: CEO and President
Holdings: 175,511 shares
Current Value: $91,266
Latest Transaction: Jan 07 2008
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID C BUPP in NAVIDEA BIOPHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.36 | 200,000 | 72,000 | 200,000 | |
| Dec 28 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.32 | 50,000 | 16,000 | 450,000 | |
| Dec 28 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.32 | 500,000 | 160,000 | 500,000 | |
| Jul 26 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.31 | 20,000 | 6,200 | 20,000 | |
| Jul 26 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.31 | 180,000 | 55,800 | 320,000 | |
| Jul 09 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.31 | 500,000 | 155,000 | 500,000 | |
| Jul 09 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.31 | 3,225,806 | 1,000,000 | 3,225,806 | |
| Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.27 | 300,000 | 81,000 | 300,000 | |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.27 | 9,400 | 2,538 | 175,511 | 166.1 K to 175.5 K (+5.66 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.26 | 600 | 156 | 166,111 | 165.5 K to 166.1 K (+0.36 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,886 | 0 | 165,511 | 149.6 K to 165.5 K (+10.62 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 67,550 | 0 | 149,625 | 82.1 K to 149.6 K (+82.30 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 24,200 | 0 | 82,075 | 57.9 K to 82.1 K (+41.81 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.26 | 10,000 | 2,600 | 438,500 | 428.5 K to 438.5 K (+2.33 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.25 | 30,000 | 7,500 | 428,500 | 398.5 K to 428.5 K (+7.53 %) |
| May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 24,200 | 0 | 398,500 | 422.7 K to 398.5 K (-5.73 %) |
| Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.26 | 200,000 | 52,000 | 200,000 | |
| Dec 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Sell | S | 0.26 | 2,000 | 520 | 422,700 | 424.7 K to 422.7 K (-0.47 %) |
| Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.27 | 8,500 | 2,295 | 424,700 | 416.2 K to 424.7 K (+2.04 %) |
| Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.28 | 10,700 | 2,943 | 416,200 | 405.5 K to 416.2 K (+2.64 %) |
| Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.28 | 5,000 | 1,400 | 405,500 | 400.5 K to 405.5 K (+1.25 %) |
| May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.38 | 15,000 | 5,700 | 400,500 | 385.5 K to 400.5 K (+3.89 %) |
| May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.34 | 5,000 | 1,700 | 385,500 | 380.5 K to 385.5 K (+1.31 %) |
| May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.32 | 5,000 | 1,575 | 380,500 | 375.5 K to 380.5 K (+1.33 %) |
| May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.33 | 10,000 | 3,300 | 375,500 | 365.5 K to 375.5 K (+2.74 %) |
| May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.33 | 15,000 | 4,950 | 365,500 | 350.5 K to 365.5 K (+4.28 %) |
| Apr 18 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.40 | 4,000 | 1,600 | 57,875 | 53.9 K to 57.9 K (+7.42 %) |
| Apr 18 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.42 | 3,000 | 1,260 | 53,875 | 50.9 K to 53.9 K (+5.90 %) |
| Dec 16 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.46 | 125,000 | 57,500 | 125,000 | |
| Dec 16 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
| Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.39 | 200,000 | 78,000 | 200,000 | |
| Nov 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.40 | 5,000 | 1,975 | 50,875 | 45.9 K to 50.9 K (+10.90 %) |
| Aug 20 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.39 | 10,000 | 3,900 | 350,500 | 340.5 K to 350.5 K (+2.94 %) |
| Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.49 | 150,000 | 73,500 | 150,000 | |
| May 26 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.43 | 10,000 | 4,300 | 340,500 | 330.5 K to 340.5 K (+3.03 %) |
| May 25 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.47 | 14,000 | 6,580 | 330,500 | 316.5 K to 330.5 K (+4.42 %) |
| May 19 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.50 | 15,000 | 7,500 | 316,500 | 301.5 K to 316.5 K (+4.98 %) |
| Apr 12 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,000 | 0 | 301,500 | 316.5 K to 301.5 K (-4.74 %) |
| Mar 10 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.50 | 375,000 | 187,500 | 375,000 | |
| Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.30 | 150,000 | 45,000 | 150,000 |
Page: 1